ストックスクリーナーアプリを入手
46.25
0.79%
-0.37
アフターアワーズ：
46.25
前日終値:
$46.62
開ける：
$46.77
24時間の取引高:
539.63K
Relative Volume:
0.94
時価総額：
$2.41B
収益：
$15.13M
当期純損益:
$-44.05M
株価収益率:
-28.37
EPS:
-1.63
ネットキャッシュフロー:
$-47.75M
1週間 パフォーマンス:
-7.87%
1か月 パフォーマンス:
+2.39%
6か月 パフォーマンス:
+21.97%
1年 パフォーマンス:
+364.36%
1日の値動き範囲:
$45.50
$48.27
1週間の範囲:
$45.50
$51.89
52週間の値動き範囲:
$5.65
$65.60
Janux Therapeutics Inc Stock (JANX) Company Profile
名前
Janux Therapeutics Inc
セクター
電話
(858) 751-4493
住所
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-04-06 | 開始されました | Wedbush | Outperform |
| 2022-11-14 | 開始されました | William Blair | Outperform |
Janux Therapeutics Inc (JANX) 最新ニュース
Blue Owl Capital Holdings LP Acquires Shares of 40,000 Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Insider Sale: Chief Business Officer Andrew Meyer Sells 50,000 S - GuruFocus.com
Janux Therapeutics exec sells over $230k in company stock By Investing.com - Investing.com South Africa
Janux Therapeutics CEO sells over $1.15 million in company stock - Investing.com India
Janux therapeutics executive sells $2.3 million in stock By Investing.com - Investing.com Canada
Janux therapeutics executive sells $2.3 million in stock - Investing.com
Janux Therapeutics exec sells over $230k in company stock - Investing.com
Janux Therapeutics CEO sells over $1.15 million in company stock - Investing.com
Get in on Janux Therapeutics Inc’s (JANX) buy-in window today! - SETE News
Taking a look at what insiders are doing to gauge the Janux Therapeutics Inc (JANX)’s direction - Knox Daily
Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024? - Insider Monkey
Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024? - Yahoo Finance
14,274 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Profund Advisors LLC - MarketBeat
10 Best Performing Small-Cap Stocks in 2024 - Insider Monkey
Samlyn Capital LLC Purchases 28,312 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Logos Global Management LP Grows Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics Inc (JANX)’s stock rises to 50.26 per share - US Post News
Market Momentum Report: Janux Therapeutics Inc (JANX)’s Positive Close at 50.26 - The Dwinnex
Samlyn Capital LLC Purchases 28,312 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Stifel analysts initates a Buy rating for Janux Therapeutics Inc (JANX) - Knox Daily
HighVista Strategies LLC Makes New Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Victory Capital Management Inc. Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
HighVista Strategies LLC Buys Shares of 23,332 Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Rhumbline Advisers Purchases 11,085 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Lennar, Bitdeer, and More Stocks See Action From Investor Activists - Barron's
How To Trade (JANX) - Stock Traders Daily
Janux Therapeutics Inc (JANX) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Jamf’s (JAMF) Market Outperform Rating Reaffirmed at JMP Securities - Defense World
Is Jamf Holding Corp (JAMF) positioned for future growth? - SETE News
The Psychology of Jaguar Health Inc Inc. (JAGX) Price Performance: Understanding Market Sentiment - The InvestChronicle
JNVR’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Jamf's (JAMF) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat
Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 8% - Defense World
Janux Therapeutics (NASDAQ:JANX) Shares Down 3.6% - MarketBeat
Janux Therapeutics (NASDAQ:JANX) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Janux Therapeutics (NASDAQ:JANX) Given "Overweight" Rating at Cantor Fitzgerald - MarketBeat
Janux Therapeutics Inc (JANX) Becoming More Attractive for Investors - Knox Daily
You might want to take a look at Janux Therapeutics Inc (JANX) now - SETE News
TD Asset Management Inc Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Quest Partners LLC Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks - Yahoo Finance
Bank of New York Mellon Corp Purchases 66,340 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Bank of New York Mellon Corp Grows Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last? - Yahoo Finance
Avalon Ventures entities and Jay Lichter sell over $21 million in Janux Therapeutics stock - Investing.com India
Avalon Ventures entities and Jay Lichter sell over $21 million in Janux Therapeutics stock - Investing.com
Ventures Xi L.P. Avalon Sells 108,365 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
10 Largest Biotech Hedge Funds and Their Top Stock Picks - Insider Monkey
Potential Price Increase for Janux Therapeutics Inc (JANX) After Recent Insider Activity - Knox Daily
Janux Therapeutics Inc (JANX) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
大文字化:
|
ボリューム (24 時間):